Eden Healthcare Solutions

edenhcs.com.au

At Eden Healthcare Solutions, we specialize in providing equipment to hospitals, special schools and aged care facilities. We also have a showroom open to the public and a wide range of equipment designed to help elderly people remain independent in their own homes. We value honest, open, two-way communication, working to build long-term relationships with a deep understanding of our client’s needs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

LABCORP COMPLETES ACQUISITION OF PERSONAL GENOME DIAGNOSTICS

Labcorp | February 21, 2022

news image

Labcorp a leading global life sciences company, announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products. The addition of PGDx and its technology complements and accelerates Labcorp’s existing liquid biopsy capabilities and expands Labcorp’s leading oncology portfolio of next-generation sequencing (NGS)-based genomic profiling capabilities, posit...

Read More

VIGILANZ LAUNCHES COVID QUICK START SOFTWARE THAT GIVES HOSPITALS CUSTOMIZABLE REAL-TIME ALERTS AND REPORTS TO MANAGE VIRAL OUTBREAKS

Prnewswire | May 21, 2020

news image

Hospitals can prepare for additional waves of COVID-19 and flu season in a matter of weeks, with no payments for six months. COVID Quick Start gives hospitals customizable real-time alerts and reports to manage viral outbreaks and exposures. Read More

Research, PHARMA TECH

ASKBIO RECEIVES EC ORPHAN DRUG DESIGNATION FOR AB-1003 VIA BRAINVECTIS

Asklepios BioPharmaceutical, Inc. (AskBio) | March 01, 2023

news image

Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, recently announced that the European Commission (EC) has granted orphan drug designation to AB-1003 (also known as LION-101) for the treatment of limb-girdle muscular dystrophy (LGMD). AB-1003 is an investigational recombinant adeno-associated virus (AAV) based gene therapy that is being developed as a one-time intravenous infusion for patients with LGMD type 2I/R9. The disease affects 4.5 people per million w...

Read More

Business Insights

ENCLARA PHARMACIA EARNS FIVE YEAR CONTRACT EXTENSION WITH VITAS HEALTHCARE

Enclara Pharmacia | February 18, 2022

news image

Enclara Pharmacia the market leader in comprehensive pharmacy benefits management (PBM) services to the hospice community, has announced a five-year contract extension to continue providing comprehensive patient medication management services to VITAS Healthcare, the nation’s leading provider of hospice and palliative care. The contract extension affirms the longstanding collaboration between the two companies based on excellence, innovation and quality care for hospice patients and their ...

Read More
news image

Business Insights

LABCORP COMPLETES ACQUISITION OF PERSONAL GENOME DIAGNOSTICS

Labcorp | February 21, 2022

Labcorp a leading global life sciences company, announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products. The addition of PGDx and its technology complements and accelerates Labcorp’s existing liquid biopsy capabilities and expands Labcorp’s leading oncology portfolio of next-generation sequencing (NGS)-based genomic profiling capabilities, posit...

Read More
news image

VIGILANZ LAUNCHES COVID QUICK START SOFTWARE THAT GIVES HOSPITALS CUSTOMIZABLE REAL-TIME ALERTS AND REPORTS TO MANAGE VIRAL OUTBREAKS

Prnewswire | May 21, 2020

Hospitals can prepare for additional waves of COVID-19 and flu season in a matter of weeks, with no payments for six months. COVID Quick Start gives hospitals customizable real-time alerts and reports to manage viral outbreaks and exposures. Read More

news image

Research, PHARMA TECH

ASKBIO RECEIVES EC ORPHAN DRUG DESIGNATION FOR AB-1003 VIA BRAINVECTIS

Asklepios BioPharmaceutical, Inc. (AskBio) | March 01, 2023

Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, recently announced that the European Commission (EC) has granted orphan drug designation to AB-1003 (also known as LION-101) for the treatment of limb-girdle muscular dystrophy (LGMD). AB-1003 is an investigational recombinant adeno-associated virus (AAV) based gene therapy that is being developed as a one-time intravenous infusion for patients with LGMD type 2I/R9. The disease affects 4.5 people per million w...

Read More
news image

Business Insights

ENCLARA PHARMACIA EARNS FIVE YEAR CONTRACT EXTENSION WITH VITAS HEALTHCARE

Enclara Pharmacia | February 18, 2022

Enclara Pharmacia the market leader in comprehensive pharmacy benefits management (PBM) services to the hospice community, has announced a five-year contract extension to continue providing comprehensive patient medication management services to VITAS Healthcare, the nation’s leading provider of hospice and palliative care. The contract extension affirms the longstanding collaboration between the two companies based on excellence, innovation and quality care for hospice patients and their ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us